Abstract
Small vessel vasculitis of the kidney is an inflammatory disorder that results in glomerulonephritis. Current treatment regimes have proved effective, with patient survival rates of 80% at five years. Of the 20% that die, a significant number of deaths are due to the side effects of therapies, and immunosuppression. A more tailored approach is required that targets the cells involved rather than generally restraining the immune system. This can only be achieved by increasing our knowledge of disease pathogenesis.
Original language | English |
---|---|
Pages (from-to) | 1142-8 |
Number of pages | 7 |
Journal | Current Opinion in Investigational Drugs |
Volume | 6 |
Issue number | 11 |
Publication status | Published - 1 Nov 2005 |